XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.3
EPT - Condensed Consolidated Statements of Equity for the three and nine months ended September 30, 2024 and 2023 - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Distributions in excess of accumulated earnings
Accumulated other comprehensive income, net
Noncontrolling interest
Balance at period beginning (in shares) at Dec. 31, 2022   64,605        
Balance at period beginning at Dec. 31, 2022 $ 5,895,116 $ 6 $ 6,750,076 $ (1,080,176) $ 46,466 $ 178,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 360,359     340,434   19,925
Change in fair value of derivatives and amortization of swap settlements 9,205       8,892 313
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   3        
Sale of common stock, net (231)   (231)      
Equity based compensation costs 9,935   9,598     337
Retirement of common stock, net (in shares)   (437)        
Retirement of common stock, net (95,657)   (95,657)      
Changes in the redemption value of redeemable noncontrolling interest (2,810)   (2,770)     (40)
Distributions to noncontrolling interest (24,006)         (24,006)
Redemptions of noncontrolling interest (in shares)   14        
Redemptions of noncontrolling interest (609)   (100)     (509)
Common stock dividends (444,855)     (444,855)    
Balance at period end (in shares) at Sep. 30, 2023   64,185        
Balance at period end at Sep. 30, 2023 5,706,447 $ 6 6,660,916 (1,184,597) 55,358 174,764
Balance at period beginning (in shares) at Jun. 30, 2023   64,183        
Balance at period beginning at Jun. 30, 2023 5,762,005 $ 6 6,657,481 (1,123,594) 51,385 176,727
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 93,009     87,282   5,727
Change in fair value of derivatives and amortization of swap settlements 4,113       3,973 140
Issuance of common stock under:            
Sale of common stock, net (106)   (106)      
Equity based compensation costs 2,289   2,211     78
Changes in the redemption value of redeemable noncontrolling interest 1,395   1,317     78
Distributions to noncontrolling interest (7,973)         (7,973)
Redemptions of noncontrolling interest (in shares)   2        
Redemptions of noncontrolling interest 0   13     (13)
Common stock dividends (148,285)     (148,285)    
Balance at period end (in shares) at Sep. 30, 2023   64,185        
Balance at period end at Sep. 30, 2023 5,706,447 $ 6 6,660,916 (1,184,597) 55,358 174,764
Balance at period beginning (in shares) at Dec. 31, 2023   64,203        
Balance at period beginning at Dec. 31, 2023 5,593,978 $ 6 6,656,720 (1,267,536) 33,556 171,232
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 509,613     484,069   25,544
Change in fair value of derivatives and amortization of swap settlements (15,925)       (15,382) (543)
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   58        
Stock option and restricted stock plans, net 12,313   12,313      
Sale of common stock, net (580)   (580)      
Equity based compensation costs 5,734   5,539     195
Changes in the redemption value of redeemable noncontrolling interest (2,293)   (2,436)     143
Changes in noncontrolling interest from acquisition 24,930         24,930
Distributions to noncontrolling interest (26,193)         (26,193)
Redemptions of noncontrolling interest (in shares)   6        
Redemptions of noncontrolling interest (1,076)   (292)     (784)
Common stock dividends (472,141)     (472,141)    
Balance at period end (in shares) at Sep. 30, 2024   64,267        
Balance at period end at Sep. 30, 2024 5,628,360 $ 6 6,671,264 (1,255,608) 18,174 194,524
Balance at period beginning (in shares) at Jun. 30, 2024   64,210        
Balance at period beginning at Jun. 30, 2024 5,654,500 $ 6 6,659,313 (1,216,557) 38,877 172,861
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 125,487     118,424   7,063
Change in fair value of derivatives and amortization of swap settlements (21,433)       (20,703) (730)
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   51        
Stock option and restricted stock plans, net 11,351   11,351      
Sale of common stock, net (467)   (467)      
Equity based compensation costs 1,991   1,923     68
Changes in the redemption value of redeemable noncontrolling interest (609)   (813)     204
Changes in noncontrolling interest from acquisition           24,930
Distributions to noncontrolling interest (9,118)         (9,118)
Redemptions of noncontrolling interest (in shares)   6        
Redemptions of noncontrolling interest (797)   (43)     (754)
Common stock dividends (157,475)     (157,475)    
Balance at period end (in shares) at Sep. 30, 2024   64,267        
Balance at period end at Sep. 30, 2024 $ 5,628,360 $ 6 $ 6,671,264 $ (1,255,608) $ 18,174 $ 194,524